Evaluate the Efficacy of an Oral Health Behavioral Intervention in People With Diabetes
Clinical Study to Evaluate the Efficacy of an Oral Health Behavioral Intervention on Medical and Dental Claims in People With Diabetes
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
New York
-
Long Island City, New York, United States, 11101
- Decentralized Site - Virtual/Remote (NY, USA)
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Consented to participation in the Fidelis Care Diabetes Care program.
- Aged 18 years and older
- English speaking.
- Willing and able to receive text messages, and participate in online activities for the duration of the program.
- Diagnosis of Type 2 Diabetes.
Exclusion Criteria:
- Severe cognitive impairment.
- General anesthesia in the past 3 months.
- Type 1 diabetes.
- Self-reported pregnant.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Type 2 Diabetes
This is a single-group study.
All subjects will be enrolled in the experimental group.
|
All subjects will receive a behavioral intervention through text messages with links to educational pages about oral health or diabetes.
Subjects will have the option of selecting in to the product intervention.
This is an opt-in product intervention, and it is expected that not all subjects will opt-in.
Subjects will need to re-order the product every 3 months.
All subjects who order product will receive a toothbrush, toothpaste, and mouthwash.
This is an opt-in product intervention, and it is expected that not all subjects will opt-in.
Subjects will need to re-order the product every 3 months.
All subjects who order product will receive a toothbrush, toothpaste, and mouthwash.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dental Claims
Time Frame: 12 months
|
Percentage of preventive dental claims compared to treatment dental claims
|
12 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Product usage
Time Frame: 12 months
|
Number of subjects who opt-in to the product intervention
|
12 months
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Endocrine System Diseases
- Mouth Diseases
- Stomatognathic Diseases
- Metabolic Diseases
- Glucose Metabolism Disorders
- Diabetes Mellitus
- Nutritional and Metabolic Diseases
- Diabetes Mellitus, Type 2
- Periodontal Diseases
- Pyridines
- Heterocyclic Compounds, 1-Ring
- Heterocyclic Compounds
- Chemical Actions and Uses
- Inorganic Chemicals
- Elements
- Metals
- Biomedical and Dental Materials
- Manufactured Materials
- Technology, Industry, and Agriculture
- Specialty Uses of Chemicals
- Metals, Heavy
- Transition Elements
- Pyridinium Compounds
- Cosmetics
- Zinc
- Cetylpyridinium
- Mouthwashes
- cytidylyl-(3'-5')-cytidine
Other Study ID Numbers
Other Study ID Numbers
- CRO-2026-05-GoMo-Diabetes-GJ
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.